Opthea Ltd (OPT)
2.77
-0.06
(-2.12%)
USD |
NASDAQ |
May 31, 16:00
2.78
+0.01
(+0.36%)
After-Hours: 20:00
Opthea Cash from Financing (Quarterly)
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
December 31, 2013 | 0.00 |
December 31, 2012 | 0.00 |
December 31, 2011 | 0.00 |
December 31, 2010 | 0.00 |
December 31, 2009 | 0.00 |
December 31, 2008 | 0.00 |
December 31, 2007 | -0.0139M |
December 31, 2006 | -0.0064M |
December 31, 2005 | -3.677M |
Date | Value |
---|---|
December 31, 2004 | -11.60M |
December 31, 2003 | -0.3662M |
December 31, 2002 | 0.056M |
December 31, 2001 | 0.0455M |
December 31, 2000 | 12.91M |
December 31, 1999 | 0.098M |
December 31, 1998 | 0.2786M |
December 31, 1996 | 0.7042M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
Kazia Therapeutics Ltd | -- |
Immutep Ltd | -- |
Alterity Therapeutics Ltd | -- |
Mesoblast Ltd | 38.76M |
Immuron Ltd | -- |